AUS
NZ
UK
CA
USA
IND
Weak Performance in FY 18: Japara Healthcare Ltd.âs (ASX:JHC) stock fell 4.4% on August 27, 2018 after the company reported 15.8% fall in FY18 EBITDA to $50.7 million and 21.5% fall in the net profit after tax (NPAT) to $23.3 million.
[optin-monster-shortcode id="wxhmli4jjedneglg1trq"]
However, in FY 18, the total revenue increased by 3% to $373.2 million. FY 18 proved to be a challenging year for the company, and the earnings were affected by occupancy pressures and Government funding cuts, that included the absence of ACFI indexation.
The group did witness better occupancy in second half of year, and developments such as Noosa Brownfields (about 12 new places) were opened. Despite the challenges, the group has been investing in business with acquisitions such as Riviera Health portfolio. JHC now expects 5% to 10% growth in FY19 EBITDA over FY18.
JHC stock has fallen 1.09% in three months as on August 24, 2018 and is trading at a P/E of 18.92x.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a companyâs prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkineâs team of analysts bought you handpicked report for âTop 25 Dividend Stocks For 2018.â
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com  and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.
